Please see below for a list of selected publications by Dr. Jane Burns. You can view a complete list of Burns' publications on PubMed.

  1. Moskowitz SM, Emerson JC, McNamara S, Shell RD, Orenstein DM, Rosenbluth D, Katz MF, Ahrens R, Hornick D, Joseph PM, Gibson RL, Aitken ML, Benton WW, Burns JL: Randomized trial of biofilm testing to select antibiotics for cystic fibrosis airway infection. Pediatr Pulmonol 46 (2):184-192, 2011. PMCID: PMC3479399.
  2. Treggiari MM, Retsch-Bogart G, Mayer-Hamblett N, Khan U, Kulich M, Kronmal R, Williams J., Hiatt P, Gibson RL, Spencer T, Orenstein D, Chatfield BA, Froh DK, Burns JL, Rosenfeld M, Ramsey BW: Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis. Arch Pediatr Adolesc Med 165 (9):847-856, 2011.
  3. Mayer-Hamblett N, Kronmal RA, Gibson RL, Rosenfeld M, Retsch-Bogart G, Treggiari MM, Burns JL, Khan U, Ramsey BW for the EPIC Investigators: Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis. Pediatr Pulmonol 47 (2):125-134, 2012. PMCID: PMC3214247.
  4. Burns JL, Emerson J, Kuypers J, Campbell AP, Gibson RL, McNamara S, Worrell K, Englund JA: Respiratory viruses in children with cystic fibrosis: viral detection and clinical findings. Influenza Other Resp Viruses, 6 (3):218-223, 2012.
  5. Qin X, Zerr DM, McNutt MA, Berry JE, Burns JL, Kapur RP: Pseudomonas aeruginosa syntrophy in chronically colonized airways of cystic fibrosis patients. Antimicrob Agents Chemother 56 (11):5971-5981, 2012. PMCID: PMC3486535.
  6. Wolter DJ, Emerson JC, McNamara S, Buccat AM, Qin X, Cochrane E, Houston LS, Rogers GB, Marsh P, Prehar K, Pope CE; Blackledge M, Deziel E, Bruce KD, Ramsey BW, Gibson RL, Burns JL, Hoffman LR: Staphylococcus aureus small-colony variants are independently associated with worse lung disease in children with cystic fibrosis. Clin Infect Dis 57 (3)384-391, 2013.
  7. VanDevanter DR, Van Dalfsen JM, Burns JL, Mayer-Hamblett N. In vitro antibiotic susceptibility of initial Pseudomonas aeruginosa isolates from US cystic fibrosis patients. J Pediatric Infect Dis Soc 2013; in press.
  8. Clancy JP, Dupont L, Konstan MW, Billings J, Fustik S, Goss CH, Lymp J, Minic P, Quittner AL, Rubenstein RC, Young KR, Saiman L, Burns JL, Govan JR, Ramsey B, Gupta R for the Arikace® Study Group. Phase II studies of nebulised Arikace® in CF patients with Pseudomonas aeruginosa infection. Thorax 68 (9):818-825, 2013. PMCID: PMC3756431.
  9. Tullis DE, Burns JL, Retsch-Bogart GZ, Bresnik M, Henig NR, Lewis SA, LiPuma JJ for the AZLI Burkholderia Study Group. Inhaled Aztreonam for chronic Burkholderia
  10. Burns JL, Rolain JM. Culture-based diagnostic microbiology in cystic fibrosis: Can we simplify the complexity? J Cyst Fibros 2013; available on-line 10/3/2013; in press.